Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denise L Cecil

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2008
Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytesDenise L Cecil, Robert Terkeltaub
Breast Cancer Research and Treatment|November 30, 2021
Breast cancer vaccines for treatment and preventionMary L Disis, Denise L Cecil
Journal of Vascular Research|November 25, 2010
Arterial calcification is driven by RAGE in Enpp1-/- miceDenise L Cecil, Robert A Terkeltaub
Oncoimmunology|May 6, 2015
Th1 epitope selection for clinically effective cancer vaccinesMary L Disis, William C Watt, Denise L Cecil
Seminars in Immunopathology|December 16, 2016
Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancerWilliam C Watt, Denise L Cecil, Mary L Disis
Arthritis and Rheumatism|January 11, 2005
Role of interleukin-8 in PiT-1 expression and CXCR1-mediated inorganic phosphate uptake in chondrocytesDenise L Cecil, David M Rose, Robert Terkeltaub, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2005
Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end productsDenise L Cecil, Kristen Johnson, John Rediske, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 6, 2022
COX-2 Inhibitors Decrease Expression of PD-L1 in Colon Tumors and Increase the Influx of Type I Tumor-infiltrating LymphocytesDenise L Cecil, Ekram A Gad, Lauren R Corulli, et al.
Cancer Research|April 30, 2014
Elimination of IL-10-inducing T-helper epitopes from an IGFBP-2 vaccine ensures potent antitumor activityDenise L Cecil, Gregory E Holt, Kyong Hwa Park, et al.
Breast Cancer Research and Treatment|June 11, 2013
T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposityDenise L Cecil, Kyong Hwa Park, Ekram Gad, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2008
Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytesDenise L Cecil, Robert Terkeltaub
Breast Cancer Research and Treatment|November 30, 2021
Breast cancer vaccines for treatment and preventionMary L Disis, Denise L Cecil
Journal of Vascular Research|November 25, 2010
Arterial calcification is driven by RAGE in Enpp1-/- miceDenise L Cecil, Robert A Terkeltaub
Oncoimmunology|May 6, 2015
Th1 epitope selection for clinically effective cancer vaccinesMary L Disis, William C Watt, Denise L Cecil
Seminars in Immunopathology|December 16, 2016
Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancerWilliam C Watt, Denise L Cecil, Mary L Disis
Arthritis and Rheumatism|January 11, 2005
Role of interleukin-8 in PiT-1 expression and CXCR1-mediated inorganic phosphate uptake in chondrocytesDenise L Cecil, David M Rose, Robert Terkeltaub, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2005
Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end productsDenise L Cecil, Kristen Johnson, John Rediske, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 6, 2022
COX-2 Inhibitors Decrease Expression of PD-L1 in Colon Tumors and Increase the Influx of Type I Tumor-infiltrating LymphocytesDenise L Cecil, Ekram A Gad, Lauren R Corulli, et al.
Cancer Research|April 30, 2014
Elimination of IL-10-inducing T-helper epitopes from an IGFBP-2 vaccine ensures potent antitumor activityDenise L Cecil, Gregory E Holt, Kyong Hwa Park, et al.
Breast Cancer Research and Treatment|June 11, 2013
T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposityDenise L Cecil, Kyong Hwa Park, Ekram Gad, et al.
Pageof 2